Alok Srivastava

Specialty: Hematology - Hemophilia research

Location: Global

Tier: ELITE

H-Index: 110

Years Active: 0

Hospital Affiliations

• CMC Vellore - Faculty

Key Publications

1. "WFH Guidelines for the Management of Hemophilia, 3rd edition." - Haemophilia (2020)
2. "Hemostasis - A Balancing Act." - N Engl J Med (2023)
3. "International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update." - Transplant Cell Ther (2024)
4. "Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study." - Blood (2025)
5. "Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial." - Lancet (2023)

Knowledge Graph Relationships

Alok Srivastava is a Hematology - Hemophilia research specialist affiliated with CMC Vellore. Authored 5 scholarly articles.